(AMI) and early thereafter was not recommended; a waiting period of 2 to 3 months after the acute event was advised.* However, angiography early after infarction3e8 and even in the acute stage of AMIS-" has proved to be feasible and safe. Furthermore, acute angiography in evolving myocardial infarction is currently being used for applying fibrinolytic agents into the diseased coronary artery12-17 or for assessing coronary lesions preceding emergency coronary artery surgical revascularization.18 The knowledge which emerged from angiography after AM1 is considered in this article. relation to myocardial infarction in living humans was unknown. Most of our knnwledge had been derived from autopsy studies and thus involved a highly selective sample of the population studied. Angiography in the acute stages of myocardial infarction revealed that the rate of a complete coronary artery occlusion progressively declined as the time after onset of symptoms increased (Table  I) .3*7*8*11.15*1s-22 The frequency of a total occlusion within 6 hours after onset of symptoms is 80% to 91%, at 6 to 24 hours 67%, at 2 weeks 53%, at 4 weeks 45 % , at 6 to 8 weeks 47 % , at 4 to 6 months 50%) and at 7 to 12 months 46 % . Although these findings provide no direct evidence for spontaneous recanalization, they strongly suggest that this may occur after infarction. Direct evidence for spontaneous recanalization would require serial angiograms in the same person.
Spontaneous recanalization, probably as a consequence of endogenous thrombolysis, apparently occurs only in the first hours and weeks after AM1 and levels off after 2 weeks. Whatever complex pathogenetic processes are involved, the onset of a transmural myocardial infarction is associated with total coronary artery obstruction, which apparently is transient in many patients. From recent experience with intracoronary streptokinase it appears that an occlusive thrombus, which can be dissolved in +80% of patients, plays a major role in the process. than with persisting occlusion of the infarct vessel in patients with a first transmural AMI, who were catheterized 6 to 8 weeks after the acute event. These findings may have an important bearing upon the evaluation of the technique of intracoronary fibrinolytic treatment and stress the necessity of randomized studies.
Extent of coronary artery disease in survivors of AMI.
As coronary angiography has not been routinely performed in patients who are asymptomatic after infarction, most studies tend to be biased toward high-risk patients. Thus, much of our knowledge of postinfarct patients or complicated transfers from coronary anatomy is derived from referred sympother hospitals, in an attempt to simulate the tomatic patients. In this article we present only data patient population with AMI seen in a community from those prospective studies2 5-7, 27,28 in which hospital. The study of Madigan et alTs was rejected patient intake was not biased toward symptomatic because of its apparent bias toward high-risk patients. In their study of 50 survivors of subendocardial infarction, 60% had multivessel disease, but 80% were catheterized for angina, which was unstable in 66%.
Only a few prospective angiographic studies after AM1 have been performed, which give insight into the overall spectrum of coronary lesions associated with the infarction. The results of these studies vary, depending mainly on the selection criteria and the eligibility.
In Table II the extent of coronary artery disease is presented in survivors of AMI. All patients were less than 70 years of age. Coronary angiography was performed 4 to 8 weeks after the acute event.
Normal vessels or minimal lesions were present in 0% to 7%) one-vessel disease was present in 23% to 58 % , two-vessel disease in 21% to 45 % , and threevessel disease in 10% to 53 % . The prevalence of left main stem artery disease varied from 1% to 11% (Table III) . The higher prevalence of left main disease (11%) in the studies of Turner et aL5 and Taylor et a1.6 compared to the other studies'*8*27~28 may be caused by patient selection. Both studies had a higher prevalence of previous AM1 (which is associated with a higher prevalence of multivessel disease) and a lower percentage of eligibility. The prevalence of multivessel disease did not differ in patients with a transmural or nontransmural AM1 (Table IV) . In transmural AM1 multivessel disease was present in 37 % to 76 % and in nontransmural AM1 this was 32 % to 76%. The prevalence of multivessel disease is significantly (p < 0.001, Mantel-Hoenszel test) higher in survivors of a transmural inferior wall AM1 than in survivors of a transmural anterior wall AM1 (Table V) . The prevalence of multivessel disease is significantly (p < 0.001) higher in patients with early postinfarction angina pectoris (79% to 92% ) than in those without angina pectoris (45% to 70%) (Table VI) . Finally, in patients with a previous AM1 the presence of multivessel disease was higher (73 % to 100 % ) than in patients with a first infarction (31% to 64% ) (Table VII).
Left ventricular dysfunction in survivors of AMI. What is the extent of left ventricular damage caused by AM1 in a nonselected population? An ejection fraction less than 30 % was present in 7 % to 17 % of the patients, an ejection fraction of 30% to 49% was found in 44% to 55%) and an ejection fraction of 50% or more was present in 31% to 48% (Table  VIII) . Similar data were found with radionuclide determined ejection fractions.27
The ejection fraction was significantly lower in patients with multivessel disease than in those with single-vessel disease. 7,8 In patients with a total occlusion of the infarct vessel the ejection fraction was lower and the impairment of left ventricular wall motion was higher than in those with a lesser degree of obstruction of the infarct vessel.sj26 Left ventricular damage was more severe with anterior wall myocardial infarction than with inferior wall myocardial infarction. 6-*,26 A severely depressed left ventricular function was found in patients with previous myocardial infarction. Apparently, a welldeveloped collateral circulation improved the ejection fraction and decreased the size of akinetic segments.8* 3o
Prognostic value of angiography and ventriculography soon after AMI. In patients younger than 65 years, the value of angiography and ventriculography as determinants of prognosis after infarction has been investigated. 6,7,28,31 Sanz et aL31 found that the ejection fraction and the number of diseased vessels were the only independent invasive predictors of survival during a follow-up study of 60 months. Patients with a normal ejection fraction, regardless of the number of diseased vessels, lived longest. The probability of survival of patients with an ejection fraction of 21% to 49% ranged from 78% for patients with three-vessel disease to 95% for those with single-vessel disease. The poorest prognosis corresponded to an ejection fraction less than 20%: 30% to 75% depending on the number of diseased vessels. According to the 30-month follow-up study of Taylor et al., 6 univariate analysis showed that low ejection fraction, proximal left anterior descending coronary artery disease, and three-vessel disease were associated with a high risk of sudden cardiac death. However, multivariate analysis of 30 clinical and laboratory variables identified previous myocardial infarction and an ejection fraction less than 40% as predictors of death. Additional information was not provided by the other variables once these two variables were considered. According to de Feyter et al.,7 patients with an ejection fraction less than 30% and three-vessel disease formed a highrisk group for cardiac death. During a mean followup of 28 months, 10 of the 11 cardiac deaths occurred in this high-risk group.
Roubin et al.% showed that three-vessel disease had a lower survival rate at 1 year than two-and one-vessel disease. Also, although not at a significant level, an ejection fraction lower than 50% was associated with a lower l-year survival rate. Thus, it appears that cardiac death in survivors of AM1 is related to the extent of coronary artery disease and the severity of left ventricular dysfunction.
Angiography in all survivors of AMI? Cardiac catheterization can be performed relatively safely early after a sustained myocardial infarction. Of a total of 486 patients who underwent angiography, there were no procedure-related deaths and major complications occurred in 1% to 3% .3*5-7 Should we then proceed to perform coronary angiography before discharge in all patients after myocardial infarction in an attempt to guide therapy to assess prognosis?
Certainly, patients recovering from AMI, who are symptomatic, should be appropriately evaluated; this may include coronary angiography and left ventriculography.
However, is there a need for angiography in asymptomatic postinfarction patients? Two recent studies32,33 have shown that surgery is not superior to medical treatment for improving survival rates in asymptomatic postinfarction patients. On the other hand, to assess prognosis and to identify high-risk patients clinical variables or noninvasive tests such as exercise ECGs and radionuclide studies appear to be appropriate and only those with evidence of inducible ischemia should undergo cardiac catheterization.34 Therefore, coronary angiography is reserved only for symptomatic patients not responding adequately to optimal medical treatment in order to assess operability. 
